BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 29308117)

  • 1. Use of Adjuvant Chemotherapy among Stage II Colon Cancer Patients in 10 Population-Based National Program of Cancer Registries.
    Eheman CR; O'Neil ME; Styles TS; Thompson TD; Morris CR; Babcock FA; Chen VW
    J Registry Manag; 2016; 43(4):179-186. PubMed ID: 29308117
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Receipt of Adjuvant Chemotherapy in Stage II Colon Cancer and Overall Survival: A National Cancer Database Study.
    Enofe N; Morris AD; Liu Y; Liang W; Wu CS; Sullivan PS; Balch GG; Staley CA; Gillespie TW; Shaffer VO
    J Surg Res; 2020 Aug; 252():69-79. PubMed ID: 32244127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A population-based study of adjuvant chemotherapy for stage-II and -III colon cancers.
    Phelip JM; Molinié F; Delafosse P; Launoy G; Trétarre B; Bara S; Buémi A; Velten M; Danzon A; Ganry O; Bouvier AM; Grosclaude P; Faivre J
    Gastroenterol Clin Biol; 2010 Feb; 34(2):144-9. PubMed ID: 20079591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
    Yun HR; Kim HC; Yun SH; Lee WY
    Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.
    Sarasqueta C; Perales A; Escobar A; Baré M; Redondo M; Fernández de Larrea N; Briones E; Piera JM; Zunzunegui MV; Quintana JM;
    BMC Cancer; 2019 Jul; 19(1):735. PubMed ID: 31345187
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Benefit of Postresection Adjuvant Chemotherapy for Stage III Colon Cancer in Octogenarians: Analysis of the National Cancer Database.
    Bergquist JR; Thiels CA; Spindler BA; Shubert CR; Hayman AV; Kelley SR; Larson DW; Habermann EB; Pemberton JH; Mathis KL
    Dis Colon Rectum; 2016 Dec; 59(12):1142-1149. PubMed ID: 27824699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hospital Variability in Use of Adjuvant Chemotherapy for Patients with Stage 2 and 3 Colon Cancer.
    Daly MC; Hanseman DJ; Abbott DE; Shah SA; Paquette IM
    Dis Colon Rectum; 2016 Dec; 59(12):1134-1141. PubMed ID: 27824698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomised-controlled trial of 1-year adjuvant chemotherapy with oral tegafur-uracil versus surgery alone in stage II colon cancer: SACURA trial.
    Matsuda C; Ishiguro M; Teramukai S; Kajiwara Y; Fujii S; Kinugasa Y; Nakamoto Y; Kotake M; Sakamoto Y; Kurachi K; Maeda A; Komori K; Tomita N; Shimada Y; Takahashi K; Kotake K; Watanabe M; Mochizuki H; Nakagawa Y; Sugihara K;
    Eur J Cancer; 2018 Jun; 96():54-63. PubMed ID: 29677641
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conventional adverse features do not predict response to adjuvant chemotherapy in stage II colon cancer.
    Peng SL; Thomas M; Ruszkiewicz A; Hunter A; Lawrence M; Moore J
    ANZ J Surg; 2014 Nov; 84(11):837-41. PubMed ID: 24224835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of treatment received versus long-standing guidelines for stage III colon and stage II/III rectal cancer patients diagnosed in Alberta, Saskatchewan, and Manitoba in 2004.
    Cree M; Tonita J; Turner D; Nugent Z; Alvi R; Barss R; King C; Winget M
    Clin Colorectal Cancer; 2009 Jul; 8(3):141-5. PubMed ID: 19632928
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ubiquitin D is an independent prognostic marker for survival in stage IIB-IIC colon cancer patients treated with 5-fluoruracil-based adjuvant chemotherapy.
    Zhao S; Jiang T; Tang H; Cui F; Liu C; Guo F; Lu H; Xue Y; Jiang W; Peng Z; Yan D
    J Gastroenterol Hepatol; 2015 Apr; 30(4):680-8. PubMed ID: 25238407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Survival impact of adjuvant chemotherapy in patients with stage IIA colon cancer: Analysis of the National Cancer Database.
    Achilli P; Crippa J; Grass F; Mathis KL; D'Angelo AD; Abd El Aziz MA; Day CN; Harmsen WS; Larson DW
    Int J Cancer; 2021 Jan; 148(1):161-169. PubMed ID: 32638371
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effect of comorbidity on the use of adjuvant chemotherapy and type of regimen for curatively resected stage III colon cancer patients.
    Hsieh MC; Thompson T; Wu XC; Styles T; O'Flarity MB; Morris CR; Chen VW
    Cancer Med; 2016 May; 5(5):871-80. PubMed ID: 26773804
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Referral patterns and adjuvant chemotherapy use in patients with stage II colon cancer.
    Kirkpatrick HM; Aitelli CL; Qin H; Becerra C; Lichliter WE; McCollum AD
    Clin Colorectal Cancer; 2010 Jul; 9(3):150-6. PubMed ID: 20643619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Practice Variation in the Adjuvant Treatment of Colon Cancer in the Netherlands: A Population-based Study.
    Keikes L; Koopman M; Lemmens VEPP; VAN Oijen MGH; Punt CJA
    Anticancer Res; 2020 Aug; 40(8):4331-4341. PubMed ID: 32727761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Young age influences treatment but not outcome of colon cancer.
    Quah HM; Joseph R; Schrag D; Shia J; Guillem JG; Paty PB; Temple LK; Wong WD; Weiser MR
    Ann Surg Oncol; 2007 Oct; 14(10):2759-65. PubMed ID: 17593332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The National Cancer Data Base. Report on colon cancer.
    Jessup JM; McGinnis LS; Steele GD; Menck HR; Winchester DP
    Cancer; 1996 Aug; 78(4):918-26. PubMed ID: 8756390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adjuvant chemotherapy for t1 node-positive colon cancers provides significant survival benefit.
    Ganapathi AM; Speicher PJ; Englum BR; Castleberry AW; Migaly J; Hsu DS; Mantyh CR
    Dis Colon Rectum; 2014 Dec; 57(12):1341-8. PubMed ID: 25379998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer.
    Bos AC; van Erning FN; van Gestel YR; Creemers GJ; Punt CJ; van Oijen MG; Lemmens VE
    Eur J Cancer; 2015 Nov; 51(17):2553-61. PubMed ID: 26360411
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adjuvant chemotherapy is not associated with improved survival for all high-risk factors in stage II colon cancer.
    Verhoeff SR; van Erning FN; Lemmens VE; de Wilt JH; Pruijt JF
    Int J Cancer; 2016 Jul; 139(1):187-93. PubMed ID: 26914273
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.